Latest Breaking News On - Regina fritsche danielson - Page 1 : comparemela.com

AstraZeneca selects new heart failure target with BenevolentAI

The target was discovered leveraging the AI-driven drug discovery platform of BenevolentAI and validated by AstraZeneca.

Regina fritsche danielsonBenevolent platformPharmaceutical technology

BenevolentAI Announces Further Success With AstraZeneca Collaboration as Novel Heart Failure Target Selected

BenevolentAI Announces Further Success With AstraZeneca Collaboration as Novel Heart Failure Target Selected
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomBen atwell simon conwayAnne phelanRegina fritsche danielsonJames osbornCompany euronext amsterdamEarly developmentHead of researchEuronext amsterdamHeart failureTarget identificationSystemic lupus erythematosusBenevolent platformChief scientific officerFritsche danielson

BenevolentAI and AstraZeneca discover novel heart failure target using AI

BenevolentAI and AstraZeneca discover novel heart failure target using AI
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Regina fritsche danielsonAnne phelanUnited kingdom basedHeart failureFritsche danielson

Silence Therapeutics (SLN) Achieves $10M Milestone Payment from AstraZeneca

Silence Therapeutics (SLN) Achieves $10M Milestone Payment from AstraZeneca
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Craig toomanRegina fritsche danielsonSilence therapeuticsEarly cardiovascular

Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial

Silence Therapeutics plc, Nasdaq: SLN , an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines,.

Regina fritsche danielsonHansoh pharmaCraig toomanExchange commission onMallinckrodt pharmaceuticalsSilence therapeuticsEarly cardiovascularSecurities litigation reform actAdmission documentAnnual reportExchange commission